OBJECTIVE: To better understand why HIV incidence is substantially higher among black than white men who have sex with men (MSM), we present the first nationally representative estimates of factors that contribute to transmission - sexual behavior, antiretroviral therapy (ART) use, and viral suppression - among HIV-infected black and white MSM in the United States. DESIGN: The Medical Monitoring Project (MMP) is a complex sample survey of HIV-infected adults receiving medical care in the United States. METHODS: We used weighted interview and medical record data collected during June 2009 to May 2010 to estimate the prevalence of sexual behaviors, ART use, and viral suppression among sexually active HIV-infected black and white MSM. We used χ tests to assess significant differences between races and logistic regression models to identify factors that mediated the racial differences. RESULTS: Sexual risk behaviors among black and white MSM were similar. Black MSM were significantly less likely than white MSM to take ART (80 vs. 91%) and be durably virally suppressed (48 vs. 69%). Accounting for mediators (e.g. age, insurance, poverty, education, time since diagnosis, and disease stage) reduced, but did not eliminate, disparities in ART use and rendered differences in viral suppression among those on ART insignificant. CONCLUSION: Lower levels of ART use and viral suppression among HIV-infected black MSM may increase the likelihood of HIV transmission. Addressing the patient-level factors and structural inequalities that contribute to lower levels of ART use and viral suppression among this group will improve clinical outcomes and might reduce racial disparities in HIV incidence.
OBJECTIVE: To better understand why HIV incidence is substantially higher among black than white men who have sex with men (MSM), we present the first nationally representative estimates of factors that contribute to transmission - sexual behavior, antiretroviral therapy (ART) use, and viral suppression - among HIV-infected black and white MSM in the United States. DESIGN: The Medical Monitoring Project (MMP) is a complex sample survey of HIV-infected adults receiving medical care in the United States. METHODS: We used weighted interview and medical record data collected during June 2009 to May 2010 to estimate the prevalence of sexual behaviors, ART use, and viral suppression among sexually active HIV-infected black and white MSM. We used χ tests to assess significant differences between races and logistic regression models to identify factors that mediated the racial differences. RESULTS: Sexual risk behaviors among black and white MSM were similar. Black MSM were significantly less likely than white MSM to take ART (80 vs. 91%) and be durably virally suppressed (48 vs. 69%). Accounting for mediators (e.g. age, insurance, poverty, education, time since diagnosis, and disease stage) reduced, but did not eliminate, disparities in ART use and rendered differences in viral suppression among those on ART insignificant. CONCLUSION: Lower levels of ART use and viral suppression among HIV-infected black MSM may increase the likelihood of HIV transmission. Addressing the patient-level factors and structural inequalities that contribute to lower levels of ART use and viral suppression among this group will improve clinical outcomes and might reduce racial disparities in HIV incidence.
Authors: Gregorio A Millett; John L Peterson; Stephen A Flores; Trevor A Hart; William L Jeffries; Patrick A Wilson; Sean B Rourke; Charles M Heilig; Jonathan Elford; Kevin A Fenton; Robert S Remis Journal: Lancet Date: 2012-07-20 Impact factor: 79.321
Authors: Drenna Waldrop-Valverde; Chandra Y Osborn; Allan Rodriguez; Russell L Rothman; Mahendra Kumar; Deborah L Jones Journal: AIDS Behav Date: 2009-08-08
Authors: Alexandra M Oster; Ryan E Wiegand; Catlainn Sionean; Isa J Miles; Peter E Thomas; Lehida Melendez-Morales; Binh C Le; Gregorio A Millett Journal: AIDS Date: 2011-05-15 Impact factor: 4.177
Authors: Peter Rebeiro; Keri N Althoff; Kate Buchacz; John Gill; Michael Horberg; Hartmut Krentz; Richard Moore; Timothy R Sterling; John T Brooks; Kelly A Gebo; Robert Hogg; Marina Klein; Jeffrey Martin; Michael Mugavero; Sean Rourke; Michael J Silverberg; Jennifer Thorne; Stephen J Gange Journal: J Acquir Immune Defic Syndr Date: 2013-03-01 Impact factor: 3.731
Authors: Matthew Garnett; Yael Hirsch-Moverman; Julie Franks; Eleanor Hayes-Larson; Wafaa M El-Sadr; Sharon Mannheimer Journal: AIDS Care Date: 2017-08-09
Authors: Adam W Carrico; Erik David Storholm; Annesa Flentje; Emily A Arnold; Lance M Pollack; Torsten B Neilands; Gregory M Rebchook; John L Peterson; Agatha Eke; Wayne Johnson; Susan M Kegeles Journal: Drug Alcohol Depend Date: 2017-03-07 Impact factor: 4.492
Authors: Hong-Van Tieu; Beryl A Koblin; Carl Latkin; Frank C Curriero; Emily R Greene; Andrew Rundle; Victoria Frye Journal: J Urban Health Date: 2020-10 Impact factor: 3.671
Authors: Cyprian Wejnert; Kristen L Hess; Charles E Rose; Alexandra Balaji; Justin C Smith; Gabriela Paz-Bailey Journal: J Infect Dis Date: 2015-10-20 Impact factor: 5.226
Authors: G Paz-Bailey; A Smith; S Masciotra; W Zhang; T Bingham; C Flynn; D German; A Al-Tayyib; M Magnus; M LaLota; C E Rose; S M Owen Journal: AIDS Behav Date: 2015-12